Pat Buckley
Question:468. Deputy Pat Buckley asked the Minister for Health the position regarding the licensing of the drug naltrexone; and when it will be available on the GMS scheme to a person (details supplied). [39790/16]
View answerTuesday, 13 December 2016
Questions (468)
Written answers
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.